Cancer Health Impact Program (CHIP): Identifying Social and Demographic Associations of mHealth Access and Cancer Screening Behaviors Among Brooklyn, New York, Residents.
Adolescent
Adult
Colorectal Neoplasms
/ diagnosis
Demography
Early Detection of Cancer
/ psychology
Female
Health Promotion
Health Services Accessibility
Humans
Information Seeking Behavior
Male
Middle Aged
New York City
/ epidemiology
Prostatic Neoplasms
/ diagnosis
Smartphone
/ statistics & numerical data
Surveys and Questionnaires
Telemedicine
/ statistics & numerical data
Young Adult
Journal
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
ISSN: 1538-7755
Titre abrégé: Cancer Epidemiol Biomarkers Prev
Pays: United States
ID NLM: 9200608
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
22
07
2018
revised:
12
09
2018
accepted:
29
01
2019
pubmed:
9
2
2019
medline:
2
5
2020
entrez:
9
2
2019
Statut:
ppublish
Résumé
The Bedford-Stuyvesant (BS) and Bushwick (BW) communities of central Brooklyn, New York, are located within the 50-mile core radius of Memorial Sloan Kettering's main catchment area. Cancer is the second leading cause of death among the predominantly African American and Hispanic neighborhoods, with BS and BW having higher prostate cancer and colorectal mortality rates than New York City as a whole. There is significant opportunity to design cancer interventions that leverage the accessibility and acceptability of mobile health (mHealth) tools among the BS and BW communities. The Cancer Health Impact Program (CHIP) is a collaborative that was formed for this purpose. Through CHIP, we used a tablet-based, Health Information National Trends (HINTS)-based multimodality survey to collect and analyze social and demographic patterns of prostate cancer and colorectal cancer screening, as well as mHealth access, among BS and BW residents. Among 783 participants, 77% reported having a smartphone, 40% reported access to a mobile health application, 17% reported blood stool kit testing, and 26% of men reported PSA test screening. Multivariable logistic regression models results demonstrated that participants who reported owning smartphones, but were unsure whether they had access to a health app, were also significantly more likely to report blood stool kit testing compared with participants without smartphones. In fully adjusted models, access to a health app was not significantly associated with PSA testing. Non-Hispanic white participants were 86% less likely to report blood stool kit testing when compared with non-Hispanic black participants [OR = 0.15; 95% confidence interval (CI) 0.02-0.49]. Participants with a prior history of cancer were three times more likely to report blood stool kit testing when compared with those without cancer history (OR = 3.18; 95% CI, 1.55-6.63). For blood stool kit testing, significant differences were observed by race/ethnicity, cancer history, age, and smartphone use; for PSA screening, only age was significant in fully adjusted models. Our results demonstrate that while access to smartphones and mobile health apps may be prevalent among minority communities, other social and demographic characteristics are more likely to influence screening behaviors.
Sections du résumé
BACKGROUND
The Bedford-Stuyvesant (BS) and Bushwick (BW) communities of central Brooklyn, New York, are located within the 50-mile core radius of Memorial Sloan Kettering's main catchment area. Cancer is the second leading cause of death among the predominantly African American and Hispanic neighborhoods, with BS and BW having higher prostate cancer and colorectal mortality rates than New York City as a whole. There is significant opportunity to design cancer interventions that leverage the accessibility and acceptability of mobile health (mHealth) tools among the BS and BW communities.
METHODS
The Cancer Health Impact Program (CHIP) is a collaborative that was formed for this purpose. Through CHIP, we used a tablet-based, Health Information National Trends (HINTS)-based multimodality survey to collect and analyze social and demographic patterns of prostate cancer and colorectal cancer screening, as well as mHealth access, among BS and BW residents.
RESULTS
Among 783 participants, 77% reported having a smartphone, 40% reported access to a mobile health application, 17% reported blood stool kit testing, and 26% of men reported PSA test screening. Multivariable logistic regression models results demonstrated that participants who reported owning smartphones, but were unsure whether they had access to a health app, were also significantly more likely to report blood stool kit testing compared with participants without smartphones. In fully adjusted models, access to a health app was not significantly associated with PSA testing. Non-Hispanic white participants were 86% less likely to report blood stool kit testing when compared with non-Hispanic black participants [OR = 0.15; 95% confidence interval (CI) 0.02-0.49]. Participants with a prior history of cancer were three times more likely to report blood stool kit testing when compared with those without cancer history (OR = 3.18; 95% CI, 1.55-6.63).
CONCLUSIONS
For blood stool kit testing, significant differences were observed by race/ethnicity, cancer history, age, and smartphone use; for PSA screening, only age was significant in fully adjusted models.
IMPACT
Our results demonstrate that while access to smartphones and mobile health apps may be prevalent among minority communities, other social and demographic characteristics are more likely to influence screening behaviors.
Identifiants
pubmed: 30733308
pii: 1055-9965.EPI-18-0788
doi: 10.1158/1055-9965.EPI-18-0788
pmc: PMC6414076
mid: NIHMS1520873
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
478-485Subventions
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Informations de copyright
©2019 American Association for Cancer Research.
Références
J Community Health. 2017 Oct;42(5):1044-1061
pubmed: 28439739
Int J Environ Res Public Health. 2017 Oct 25;14(11):
pubmed: 29068377
J Med Internet Res. 2014 Jul 16;16(7):e172
pubmed: 25048379
JAMA. 2018 May 8;319(18):1914-1931
pubmed: 29801018
J Health Care Poor Underserved. 2017;28(1):362-377
pubmed: 28239007
J Med Internet Res. 2013 Dec 23;15(12):e287
pubmed: 24366061
J Med Internet Res. 2015 Mar 17;17(3):e70
pubmed: 25783036
BJU Int. 2010 Aug;106(3):322-8
pubmed: 20553251
Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1505-11
pubmed: 24802741
Cancer Nurs. 2005 Mar-Apr;28(2):108-18
pubmed: 15815180
BMC Cancer. 2015 Nov 16;15:907
pubmed: 26573809
J Gen Intern Med. 2015 Aug;30(8):1063-70
pubmed: 25691239
Gastroenterology. 2017 Apr;152(5):1217-1237.e3
pubmed: 27769517
J Med Internet Res. 2005 Jul 01;7(3):e23
pubmed: 15998614
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30
pubmed: 26742998
J Health Commun. 2011;16 Suppl 1:77-89
pubmed: 21843097
Manag Care. 2014 May;23(5):39-41
pubmed: 25019148
Yearb Med Inform. 2016 Nov 10;(1):93-108
pubmed: 27830236
JMIR Mhealth Uhealth. 2017 Dec 19;5(12):e197
pubmed: 29258981